Central nervous system (CNS) neuroblastoma forkhead box R2 (FOXR2)-activated (NB-FOXR2) is a pediatric brain tumor identified from DNA methylation profiling of a large series of CNS tumors in 2016 (1). Previously classified within primitive neuroectodermal tumors, NB-FOXR2 emerged as a cohesive entity now recognized by the World Health Organization (2), with distinct clinical and molecular features.